International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 115

Research Paper | Pharmacology Science | Volume 5 Issue 9, September 2016 | Pages: 1020 - 1026 | Iraq


Predicting Resistance to Recombinant Human Erythropoietin Therapy in CKD Patients on Maintenance Hemodialysis

Mohanad Yasir Al-Radeef, Sajida Hussein Ismail, Ali Abdul-Majid Dyab Allawi

Abstract: Background Anemia is a common complication associated with chronic kidney disease (CKD), and optimal treatment requires appropriate diagnosis, recombinant human erythropoietin (rHuEPO) and iron therapy, and close monitoring of response. Approximately 5-10 % of these patients receiving rHuEPO therapy, however, appear to be hypo-responsive to this drug. This study aimed to identify some determinants of rHuEPO hypo-responsiveness in anemic CKD patients on maintenance hemodialysis. Method Seventy patients with CKD on maintenance hemodialysis receiving rHuEPO and (20) control subjects were enrolled in this case-control prospective study. Erythropoietin resistance index (ERI), calculated as the weekly weight-adjusted dose of rHuEPO divided by the hemoglobin level was determined to evaluate the doseresponse effect of rHuEPO therapy. Determinants of rHuEPO hypo-responsiveness were identified by univariate logistic regression analyses. Results Approximately half of patients were inadequately responded to rHuEPO therapy with an ERI value >0.0365 g/kg/week/g hemoglobin. Univariate analyses revealed that duration of dialysis (years), BMI and serum albumin were the most important determinants of rHuEPO hypo-responsiveness and an inverse relationship had been found between these determinants and ERI. Conclusion easily available clinical parameters and routine laboratory parameters can predict hypo-responsiveness to rHuEPO therapy in hemodialysis patients.

Keywords: CKD, Anemia, rHuEPO hypo-responsiveness, ERI

How to Cite?: Mohanad Yasir Al-Radeef, Sajida Hussein Ismail, Ali Abdul-Majid Dyab Allawi, "Predicting Resistance to Recombinant Human Erythropoietin Therapy in CKD Patients on Maintenance Hemodialysis", Volume 5 Issue 9, September 2016, International Journal of Science and Research (IJSR), Pages: 1020-1026, https://www.ijsr.net/getabstract.php?paperid=ART20161759, DOI: https://dx.doi.org/10.21275/ART20161759

Download Citation: APA | MLA | BibTeX | EndNote | RefMan

Share This Research

Help this article reach readers, researchers and professionals.

Share activity is measured for research-engagement analytics. Only verified, unique public shares can support award tie-breaking.

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.

Download Article PDF


Rate This Article!

Top

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.